AmeriHealth Caritas: Five Crucial Interventions to Improve Health Outcomes for Black Mothers

NEWTOWN SQUARE, Pa.–(BUSINESS WIRE)–#AmeriHealthCaritas–Which high-income country is the most dangerous place to give birth? If you answered “The United States,” AmeriHealth Caritas says you would be correct. In 2021, the U.S. maternal mortality rate hit its highest level since 1965, with deaths disproportionately impacting Black women: More than 1,200 women died during pregnancy or shortly … [Read more…]

BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023

BostonGene to Present on the Power of Next-generation Immunotherapy Response Prediction Using AI-based Multiomic Data Integration WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023, which will be held from April 14 – 19, at the Orange County Convention Center … [Read more…]

Brightside Health Welcomes Chief Financial Officer Chris Murray to Executive Leadership Team

Murray brings 15+ years of strategic finance experience to continue scaling Brightside Health’s telemental health care model SAN FRANCISCO–(BUSINESS WIRE)–Brightside Health, a telehealth platform that delivers life-changing mental health care to individuals with mild-to-severe clinical depression, anxiety, and other mood disorders, announced today the appointment of Chris Murray as Chief Financial Officer. Murray will be … [Read more…]

Tivic Expands Bioelectronic Portfolio; Files Patent Application for New Approach to Non-Invasive Vagus Nerve Stimulation

SAN FRANCISCO–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it has filed its first patent in Vagus Nerve Stimulation with the U.S. Patent Office (USPTO), expanding its intellectual property portfolio into new clinical targets. Tivic’s prior patents and current products … [Read more…]

Science-Forward Skincare Brand A.P. CHEM® Debuts New Age-Decelerating Products and Stigma-Breaking Social Campaign

NEW YORK–(BUSINESS WIRE)–Today, A.P. CHEM announces the launch of their newest age-decelerating skincare aimed at the Xennial and Gen X community that is both results-driven and accessibly priced. As a science-forward skincare brand, A.P. CHEM combines the best of classic ingredients with clinically-proven Alt-Pharma™ ingredients to create a power-packed regimen. The brand’s approach to combining … [Read more…]

ArteraAI and American Cancer Society Announce New Relationship

With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease SAN FRANCISCO & ATLANTA–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new relationship today that will allow … [Read more…]

Krsnaa Diagnostics is Live on SOPHiA GENETICS

SOPHiA DDM™ for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Krsnaa Diagnostics, India’s largest diagnostic services provider in radiology and pathology, is live on SOPHiA DDM™ technology. … [Read more…]

JED and AASA Form Exclusive Partnership to Develop Comprehensive Youth Mental Health and Suicide Prevention Approach for Districts Nationwide

ALEXANDRIA, Va. & NEW YORK–(BUSINESS WIRE)–The Jed Foundation (JED) and AASA, The School Superintendents Association, are pleased to announce a multi-year initiative to develop and deploy a comprehensive approach to mental health and suicide prevention for school districts. The District Comprehensive Approach will provide PreK-12 school districts across the nation with an evidence-based framework—combined with … [Read more…]

Takeda Receives FDA Approval to Expand the Use of HYQVIA® to Treat Primary Immunodeficiency in Children

HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase], the Only Once-a-Month – Every Three or Four Weeks – Subcutaneous Immunoglobulin (ScIG), is Now Approved for People Two Years of Age and Older with Primary Immunodeficiency Approval Supported by Pivotal Phase 3 Study that Demonstrated Reliable Infection Protection in Children 2-16 Years Old CAMBRIDGE, … [Read more…]

ObjectiveHealth Announces 30th Research Center of Excellence

Nashville-based research and technology company currently has active research centers in 16 states across the country NASHVILLE, Tenn.–(BUSINESS WIRE)–#amarillo—ObjectiveHealth, a Nashville-based integrated research and technology platform company, today announced the opening of its 30th research site, Amarillo Premier Research, in Amarillo, Texas. Since establishing its first research center in Nashville in 2018, ObjectiveHealth has expanded … [Read more…]